Stacie Weninger active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Alzforum | President | - | - |
| Aratome, LLC | Director/Board Member | - | - |
| BRI-Alzan, Inc. | Director/Board Member | - | - |
| Bri-Tolan, Inc. | Director/Board Member | - | - |
Eikonizo Therapeutics, Inc.
 Eikonizo Therapeutics, Inc. Medical/Nursing ServicesHealth Services Eikonizo Therapeutics, Inc. provides healthcare services. The company was founded in 2017 and is headquartered in Beverly, MA. | Director/Board Member | - | - |
Digital Cognition Technologies, Inc.
 Digital Cognition Technologies, Inc. Medical SpecialtiesHealth Technology Digital Cognition Technologies, Inc. develops detect presymptomatic cognitive impairment and aid in tracking cognitive devices. The company was founded by Randall S. Davis, Dana L. Penney and Phil A. Cooper in 2015 and is headquartered in Waltham, MA. | Director/Board Member | - | - |
Atalanta Therapeutics, Inc.
 Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Director/Board Member | - | - |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | President | - | - |
Sironax Ltd.
 Sironax Ltd. Pharmaceuticals: MajorHealth Technology Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research. | Director/Board Member | - | - |
Career history of Stacie Weninger
Former positions of Stacie Weninger
| Companies | Position | Start | End |
|---|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Stacie Weninger
| Harvard University | Doctorate Degree |
| The University of North Carolina at Charlotte | Undergraduate Degree |
Statistics
International
| United States | 15 |
| China | 2 |
Operational
| Director/Board Member | 11 |
| President | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| DENALI THERAPEUTICS INC. | Health Technology |
| Private companies | 12 |
|---|---|
Enspectra Health, Inc.
 Enspectra Health, Inc. Medical SpecialtiesHealth Technology Enspectra Health, Inc. engages in the provision of visualization of cellular structures. It develops micro-endoscopy system. The company was founded by Gabriel Sanchez, Mark Schnitzer, and Scott Delp and is headquartered in Mountain View, CA. | Health Technology |
Inscopix, Inc.
 Inscopix, Inc. BiotechnologyHealth Technology Inscopix, Inc. develops and produces miniature integrated microscopes and related devices. It is categorized under the research and development in the physical, engineering, and life sciences industry. The firm specializes in neuroscience, life science research tools, in vivo brain imaging, electrophysiology, neurotechnology, miniature microscope, calcium imaging areas. The company was founded by Mark Schnitzer, Kunal Ghosh and Abbas El Gamal in 2011 and is headquartered in Palo Alto, CA. | Health Technology |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Finance |
| Alzforum | |
| Aratome, LLC | |
| BRI-Alzan, Inc. | |
| Bri-Tolan, Inc. | |
Q-State Biosciences, Inc.
 Q-State Biosciences, Inc. BiotechnologyHealth Technology Q-State Biosciences, Inc. operates as Biotechnology Company. It offers cardiology, neurology, toxicity screening, drug discovery, drug efficacy screening, pathology modeling, optogenetic, electrophysiology, voltage and calcium signal. The company was founded by Adam E. Cohen, Kevin Eggan, David Margulies and Joel Kralj and is headquartered in Cambridge, MA. | Health Technology |
Digital Cognition Technologies, Inc.
Digital Cognition Technologies, Inc. Medical SpecialtiesHealth Technology Digital Cognition Technologies, Inc. develops detect presymptomatic cognitive impairment and aid in tracking cognitive devices. The company was founded by Randall S. Davis, Dana L. Penney and Phil A. Cooper in 2015 and is headquartered in Waltham, MA. | Health Technology |
Eikonizo Therapeutics, Inc.
Eikonizo Therapeutics, Inc. Medical/Nursing ServicesHealth Services Eikonizo Therapeutics, Inc. provides healthcare services. The company was founded in 2017 and is headquartered in Beverly, MA. | Health Services |
Atalanta Therapeutics, Inc.
Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Commercial Services |
Sironax Ltd.
Sironax Ltd. Pharmaceuticals: MajorHealth Technology Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research. | Health Technology |
- Stock Market
- Insiders
- Stacie Weninger
- Experience
